ABO and pure red-cell aplasia: In comparison to conventional antigen-unspecific immunoadsorption, ABO antigen-specific immunoadsorption (ABO-IA) using Glycosorb® might offer the benefit of effective post-HSCT PRCA treatment without the offset of affecting other blood components.